Canna~Fangled Abstracts Structural analysis of cannabinoids against EGFR-TK leads a novel target against EGFR-driven cell lines Journal List Curr Res Pharmacol Drug Discov v.3; 2022 PMC9780064 Curr Res Pharmacol Drug Discov. 2022;…Freedom WaresDecember 3, 2022
Canna~Fangled Abstracts Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer. 2016 May 17. doi: 10.18632/oncotarget.9408. Elbaz M1,2, Ahirwar D1, Ravi J1, Nasser MW1, Ganju RK1. Author information Abstract Breast…Freedom WaresMay 17, 2016
Canna~Fangled Abstracts Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway. 2016 Jan 6. doi: 10.1002/mc.22451. Ravi J1, Elbaz M1, Wani NA1, Nasser MW1, Ganju RK1. Author information Abstract JWH-015,…Freedom WaresJanuary 6, 2016
Canna~Fangled Abstracts Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer. 2015 Jan 19. pii: S1574-7891(14)00295-6. doi: 10.1016/j.molonc.2014.12.010. Elbaz M1, Nasser MW2, Ravi J3, Wani NA4, Ahirwar DK5, Zhao H6, Oghumu S7, Satoskar…Freedom WaresJanuary 19, 2015
Canna~Fangled Abstracts (R,R')-4'-Methoxy-1-naphthylfenoterol Targets GPR55-mediated Ligand Internalization and Impairs Cancer Cell Motility. Biochem Pharmacol. 2013 Dec 16. pii: S0006-2952(13)00754-5. doi: 10.1016/j.bcp.2013.11.020. (R,R')-4'-Methoxy-1-naphthylfenoterol Targets GPR55-mediated Ligand Internalization and Impairs…Freedom WaresDecember 21, 2013